Themis Medicare's promoter, Vividhmargi Trust, has pledged 27.49% of the company's total shares for a ₹135 crore debt. This raises concerns about promoter leverage and fund usage.
Detailed Coverage
Themis Medicare Promoter Pledges Significant Stake
Promoter Entity Vividhmargi Trust has pledged 2,53,17,620 equity shares of Themis Medicare Limited, representing 27.49% of the company's total share capital. ## What just happened Vividhmargi Trust has created an encumbrance on 2,53,17,620 equity shares of Themis Medicare Limited. This represents 27.49% of the company's total equity. The trust is managed by trustees Dinesh Shantilal Patel, Jayshree Dinesh Patel, and Dr. Sachin Dinesh Patel. ## Why this matters The pledge is linked to ₹135 crore in debt instruments issued by OSS Software Solutions Labs Private Limited. The stated end use of the borrowed money is for "personal use by promoters and PACs," which is a key factor for investors to monitor regarding promoter financial health and commitment. ## The backstory The encumbrance is pursuant to a Debenture Trust Deed. The debt instruments are unrated and unlisted, secured, redeemable non-convertible debentures issued by OSS Software Solutions Labs Private Limited, with CTL Trusteeship Limited as the debenture trustee for Kotak Credit Opportunities Fund Trust. ## What changes now The promoter group has now encumbered 40.96% of its total shareholding, highlighting a significant level of leverage. While the debt is not directly on Themis Medicare's books, a high promoter pledge can be a governance watch point for investors. ## Risks to watch * **High Promoter Encumbrance:** Over 40% of the promoter's stake is now pledged. * **Personal Use of Funds:** Borrowed money is for promoters' personal use, not company operations. * **Unlisted/Unrated Debt:** Implies a potentially higher risk profile for the debt instruments. ## Asset Cover Analysis The pledged shares are valued at approximately ₹284.19 crore, providing a security cover of 2.10 times against the ₹135 crore debt. ## Investor Takeaway This development highlights the promoter group's leverage. While not directly impacting Themis Medicare's operations, investors should monitor this as a key governance factor.
